Literature DB >> 21529134

Predictors of seizure freedom after resection of supratentorial low-grade gliomas. A review.

Dario J Englot1, Mitchel S Berger, Nicholas M Barbaro, Edward F Chang.   

Abstract

OBJECT: Seizures are the most frequent presenting symptom in patients with low-grade gliomas (LGGs), and significantly influence quality of life if they are uncontrolled. Achieving freedom from seizures is of utmost importance in surgical planning, but the factors associated with seizure control remain incompletely understood.
METHODS: The authors performed a systematic literature review of seizure outcomes after resection of LGGs causing seizures, examining 773 patients across 20 published series. Rates of seizure freedom were stratified across 7 variables: patient age, tumor location, preoperative seizure control with medication, seizure semiology, epilepsy duration, extent of resection, and the use of intraoperative electrocorticography (ECoG).
RESULTS: Gross-total resection was most predictive of complete seizure freedom, when compared with subtotal resection (OR 3.41, 95% CI 2.36-4.93). Other predictors of seizure freedom included preoperative seizure control on antiepileptic medication (OR 2.12, 95% CI 1.33-3.38) and duration of seizures of ≤ 1 year (OR 1.85, 95% CI 1.22-2.79). Patients with simple partial seizure semiology achieved seizure freedom less often than those with complex partial, generalized, or mixed seizure types (OR 0.46, 95% CI 0.26-0.80). No significant differences in seizure outcome were observed between adults versus children, patients with temporal lobe versus extratemporal tumors, or with the use of intraoperative ECoG.
CONCLUSIONS: Seizure control is one of the most important considerations in planning surgery for low-grade brain tumors. Gross-total resection is a critical factor in achieving seizure freedom.

Entities:  

Mesh:

Year:  2011        PMID: 21529134     DOI: 10.3171/2011.3.JNS1153

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  59 in total

1.  Evaluating the epilepsy and oncological outcomes of pediatric brain tumors causing seizures.

Authors:  Shelly Wang; Aria Fallah
Journal:  Transl Pediatr       Date:  2016-01

2.  Seizure predictors and control after microsurgical resection of supratentorial arteriovenous malformations in 440 patients.

Authors:  Dario J Englot; William L Young; Seunggu J Han; Charles E McCulloch; Edward F Chang; Michael T Lawton
Journal:  Neurosurgery       Date:  2012-09       Impact factor: 4.654

Review 3.  Treatment of epileptic seizures in brain tumors: a critical review.

Authors:  R Bauer; M Ortler; M Seiz-Rosenhagen; R Maier; J V Anton; I Unterberger
Journal:  Neurosurg Rev       Date:  2014-04-24       Impact factor: 3.042

Review 4.  Rates and predictors of seizure outcome after corpus callosotomy for drug-resistant epilepsy: a meta-analysis.

Authors:  Alvin Y Chan; John D Rolston; Brian Lee; Sumeet Vadera; Dario J Englot
Journal:  J Neurosurg       Date:  2018-05-01       Impact factor: 5.115

5.  Seizure freedom from recurrent insular low-grade glioma following laser interstitial thermal therapy.

Authors:  T P Easwaran; A Lion; A O Vortmeyer; K Kingery; McDonald Bc; J S Raskin
Journal:  Childs Nerv Syst       Date:  2020-01-11       Impact factor: 1.475

6.  Efficacy and safety of Levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma.

Authors:  Andrés F Cardona; Leonardo Rojas; Beatriz Wills; Laura Bernal; Alejandro Ruiz-Patiño; Oscar Arrieta; Enrique Jiménez Hakim; Fernando Hakim; Juan Armando Mejía; Nicolás Useche; Sonia Bermúdez; Hernán Carranza; Carlos Vargas; Jorge Otero; Luis Carlos Mayor; León Darío Ortíz; Sandra Franco; Carlos Ortíz; Miguel Gil-Gil; Carmen Balaña; Zyanya Lucia Zatarain-Barrón
Journal:  J Neurooncol       Date:  2017-11-25       Impact factor: 4.130

Review 7.  Neurocognitive functioning in adult WHO grade II gliomas: impact of old and new treatment modalities.

Authors:  Martin Klein
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

Review 8.  Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments.

Authors:  Roberta Rudà; Lorenzo Bello; Hugues Duffau; Riccardo Soffietti
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

9.  What is New in the Management of Epilepsy in Gliomas?

Authors:  Roberta Rudà; Riccardo Soffietti
Journal:  Curr Treat Options Neurol       Date:  2015-06       Impact factor: 3.598

Review 10.  Epilepsy surgery: an evidence summary.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2012-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.